MEI Pharma Net Income
| MEIPDelisted Stock | USD 3.07 0.18 6.23% |
As of the 20th of February, MEI Pharma secures the risk adjusted performance of 0.0879, and Mean Deviation of 5.5. In connection with fundamental indicators, the technical analysis model lets you check helpful technical drivers of MEI Pharma, as well as the relationship between them.
Analyzing historical trends in various income statement and balance sheet accounts from MEI Pharma's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting MEI Pharma's valuation are summarized below:MEI Pharma does not today have any fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. MEI |
Search Suggestions
| ME | Magic Eden | Cryptocurrency |
| MEC | Mayville Engineering Co | Company |
| MET-PA | MetLife Preferred Stock | Company |
| MECIX | Amg Managers Cadence | Mutual Fund |
| MEM | MAYBANK EMERGING ETF | ETF |
| ME | 23Andme Holding Co | CompanyDelisted |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, MEI Pharma reported net income of 17.78 M. This is 94.79% lower than that of the Biotechnology sector and 74.62% lower than that of the Health Care industry. The net income for all United States stocks is 96.89% higher than that of the company.
MEI Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MEI Pharma's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MEI Pharma could also be used in its relative valuation, which is a method of valuing MEI Pharma by comparing valuation metrics of similar companies.MEI Pharma is currently under evaluation in net income category among its peers.
MEI Fundamentals
| Return On Equity | -0.9 | |||
| Return On Asset | -0.23 | |||
| Current Valuation | 59.84 M | |||
| Shares Outstanding | 32.84 M | |||
| Shares Owned By Insiders | 7.60 % | |||
| Shares Owned By Institutions | 8.12 % | |||
| Number Of Shares Shorted | 2.46 M | |||
| Price To Earning | 30.29 X | |||
| Price To Book | 5.02 X | |||
| Price To Sales | 0.27 X | |||
| Revenue | 65.3 M | |||
| Gross Profit | (5.59 M) | |||
| EBITDA | 18.16 M | |||
| Net Income | 17.78 M | |||
| Cash And Equivalents | 153.25 M | |||
| Cash Per Share | 1.15 X | |||
| Total Debt | 8.36 M | |||
| Debt To Equity | 0.18 % | |||
| Current Ratio | 6.84 X | |||
| Book Value Per Share | 2.93 X | |||
| Cash Flow From Operations | (50.47 M) | |||
| Short Ratio | 0.89 X | |||
| Earnings Per Share | (4.75) X | |||
| Price To Earnings To Growth | 20.60 X | |||
| Target Price | 20.0 | |||
| Number Of Employees | 28 | |||
| Beta | 0.22 | |||
| Market Capitalization | 91.29 M | |||
| Total Asset | 41.38 M | |||
| Retained Earnings | (388.22 M) | |||
| Working Capital | 32.41 M | |||
| Current Asset | 46.75 M | |||
| Current Liabilities | 5.51 M | |||
| Net Asset | 41.38 M |
About MEI Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MEI Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MEI Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MEI Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with MEI Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if MEI Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MEI Pharma will appreciate offsetting losses from the drop in the long position's value.Moving against MEI Stock
| 0.79 | APVO | Aptevo Therapeutics | PairCorr |
| 0.73 | NIVF | NewGenIvf Group | PairCorr |
| 0.71 | TRNR | Interactive Strength | PairCorr |
| 0.51 | AFIIQ | Armstrong Flooring | PairCorr |
| 0.39 | BRK-A | Berkshire Hathaway Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to MEI Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace MEI Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back MEI Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling MEI Pharma to buy it.
The correlation of MEI Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as MEI Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if MEI Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for MEI Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in MEI Stock
If you are still planning to invest in MEI Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MEI Pharma's history and understand the potential risks before investing.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |